Torrent Pharmaceuticals Limited has informed the Exchange about Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2022

�;orrent-W PHRRmR

5th August, 2022

The Dy. General Manager (Listing-·Dept.) BSE Limited, Corporate Relationship Dept., 1 s_t Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager-Listing Dept., National Stock Exchange oflndia Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM).

Dear Sir,

Sub.: Transcript of Conference call with Analysts I Investors on Financial Results for the·

quarter ended 30th June, 2022

In continuation of our letter dated 21-Jul-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 301h June, 2022, has been placed on the Company's website at https://torrentpharma.com/pdf/investors/Q 1-FY23-Earnings-Call-Transcript.pdf

Kindly take note of the above.

Thanking you,

Yours sincerely,

For TORRENT �HARMACEUTICALS LIMITED

"'

G;�ClY' f0�

�

1)0.

\.,

'

CHINTAN M. TRIVEDI COMPANY SECRETARY

Reg.Office : Torrent House, Off Ashram Road, Ahmedabad - 380 009, India. f'.'hone: +91 79 26599000, Fax : +91 79 26582100, www.torrentpharma.com

TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126